Nantong Weizhen Pharmaceutical Technology Co., Ltd.
PrivateLast Round
Corporate Funding
Mar 9, 2022
Company Overview
Nantong Weizhen Pharmaceutical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Nantong. Its latest recorded funding round was a Corporate Funding round in March 2022.
Nantong Weizhen Pharmaceutical Technology Co., Ltd. is a research and development company that provides medical research and technical services in the pharmaceutical sector.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nantong Weizhen Pharmaceutical Technology Co., Ltd. Comparables
Compare Nantong Weizhen Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jinghua Pharmaceutical Group Co., Ltd. | 68% | |
| Beijing CAS Microneedle Technology, Ltd. | 56% | |
| Kindeva Drug Delivery | 44% |
For institutional investors. Book with your work email.
Nantong Weizhen Pharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nantong Weizhen Pharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yangtze River Delta National Innovation Center | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2022
Raised funds from Jiangsu Industrial Technology Research Institute and Yangtze River Delta National Innovation Center.
For institutional investors. Book with your work email.
Nantong Weizhen Pharmaceutical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nantong Weizhen Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Nantong Weizhen Pharmaceutical Technology Co., Ltd. a public or private company?
Nantong Weizhen Pharmaceutical Technology Co., Ltd. is a private company.
What is the current stock price of Nantong Weizhen Pharmaceutical Technology Co., Ltd.?
Nantong Weizhen Pharmaceutical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nantong Weizhen Pharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nantong Weizhen Pharmaceutical Technology Co., Ltd. worth (valuation)?
Valuation information for Nantong Weizhen Pharmaceutical Technology Co., Ltd. is not publicly available.
Can I buy Nantong Weizhen Pharmaceutical Technology Co., Ltd. stock?
Nantong Weizhen Pharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nantong Weizhen Pharmaceutical Technology Co., Ltd.'s last funding round?
Nantong Weizhen Pharmaceutical Technology Co., Ltd.'s most recent funding round was Corporate Funding on March 9, 2022.
Who are the main investors in Nantong Weizhen Pharmaceutical Technology Co., Ltd.?
Key investors in Nantong Weizhen Pharmaceutical Technology Co., Ltd. include Yangtze River Delta National Innovation Center.
Will Nantong Weizhen Pharmaceutical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Nantong Weizhen Pharmaceutical Technology Co., Ltd..
How can I track Nantong Weizhen Pharmaceutical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nantong Weizhen Pharmaceutical Technology Co., Ltd.'s shares on secondary markets.